六月 2026
rheumnow.com
显示 Similarweb 估计数据。
关联 GA4,公开验证您的网站指标
与您的成功同步
绑定 Google Analytics,验证您网站的流量及用户参与度指标
跳出率
40.15%
每次访问页数
1.99
平均访问时长
00:01:48
- 公司
- - -
- 行业
- - -
rheumnow.com的 10 大竞争对手
在 六月 2026 与 rheumnow.com 相似的前 10 名网站,按关键字流量、受众定位和市场重叠方面与 rheumnow.com 的关联性排名
Objective To evaluate the feasibility, usability and acceptability of implementing a treat-to-target (T2T) strategy supported by a Clinical Decision Support System (CDSS), in routine SLE outpatient care.Methods A 24-week, non-randomised, multicentre, clustered pilot study was conducted across four rheumatology outpatient centres. Adult patients with SLE were allocated by centre to either a T2T strategy supported by a CDSS (T2T-CDSS) or a routine outpatient care (ROC) group. The CDSS provided evidence-based treatment recommendations based on disease activity measures. Feasibility outcomes included recruitment and retention rates. Usability was assessed with the System Usability Scale (SUS), completed by physicians in the T2T-CDSS group. Acceptability was evaluated using the Treatment Satisfaction Questionnaire (TSQ) and qualitative feedback. Exploratory outcomes included disease activity, remission rates and treatment modifications.Results Of 91 screened patients, 38 were enrolled (recruitment rate 42%) and 35 completed the study (retention rate 92%). The SUS score for the CDSS was 73.8, indicating good usability. Global satisfaction scores on the TSQ were stable over time and comparable between groups. Remission was achieved at least once by 61% (11/18) of patients in the T2T-CDSS group and 59% (10/17) in the ROC group. Both treatment intensifications and de-escalations occurred more frequently in the T2T-CDSS group compared with ROC (83% vs 47%). Treatment intensifications were observed in 61% of patients in the T2T-CDSS group vs 29% in the ROC group. Treatment de-escalation, represented by glucocorticoid tapering, occurred in 39% of T2T-CDSS patients compared with 18% in ROC. No statistically significant differences were observed between groups in disease activity outcomes or remission rates.Conclusions Implementation of a T2T strategy supported by a CDSS in SLE outpatient care was feasible, usable and acceptable to patients and physicians. Although qualitative fe
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
67.42%
每次访问页数
1.53
平均访问时长
00:00:06
相似度评分
100%Though she's felt agitated recently, columnist Rena Newman is trying to walk in forgiveness and find peace amid her health issues.
- 公司
- - -
- 行业
- - -
跳出率
59.3%
每次访问页数
1.60
平均访问时长
00:02:23
The syndrome of periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA syndrome) is the most common cause of periodic fever in childhood. The current pharmacological treatment includes corticosteroids, which usually are efficacious in the management of fever episodes, colchicine, for the prophylaxis of febrile episodes, and other medication for which efficacy has not been proven so far. Tonsillectomy is an option for selected patients. Usually PFAPA syndrome resolves during adolescence, but there is increasing evidence that this condition may persist into adulthood.
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
52.86%
每次访问页数
1.89
平均访问时长
00:00:02
Sales & Marketing Director Frazer Mackenzie-Andrew 0414 958 144 frazer@medicalrepublic.com.au Production & Client Services Manager Sarah Stanbridge 0413 027 802 sarah@medicalrepublic.com.au Sales Manager (part-time) Sarah Wylie 0412 511 421 swylie@medicalrepublic.com.au EDITORIAL ENQUIRIES (and submissions) Rheuma Republic accepts submissions from contributors and experts for publication. Contact Dr Irwin Lim or Amanda Sheppeard below. Editor in Chief […]
- 公司
- - -
- 行业
- - -
跳出率
33.33%
每次访问页数
2.52
平均访问时长
00:00:18
Skincareguide.com Ltd. (“SkinCareGuide”) understands how important the privacy of personal information is to our customers. SkinCareGuide is committed to honoring your privacy. The document you are reading is our privacy policy for our websites that are accessible by patients/consumers and medical professionals. It describes what information we may collect about you, what uses we may […]
- 公司
- - -
- 行业
- - -
跳出率
50.11%
每次访问页数
1.45
平均访问时长
00:00:17
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
22.25%
每次访问页数
7.56
平均访问时长
00:04:12
Congress of Clinical Rheumatology Privacy Policy Your privacy and safety of your data is important to us. This Privacy Policy document describes types of information that is or may be collected, used or shared by www.ccrheumatology.com when you visit, use or make a purchases. If you have any additional questions or require more information about […]
- 公司
- - -
- 行业
- - -
跳出率
28.8%
每次访问页数
6.38
平均访问时长
00:02:00
If you have a pit, nodule or cord in your palm and/or the finger associated with it begins to draw into your palm, you may have Dupuytren’s Contracture (no special test is needed to diagnose this condition)
- 公司
- - -
- 行业
- - -
跳出率
41.89%
每次访问页数
2.02
平均访问时长
00:00:27
According to a new report from the American College of Rheumatology (ACR), rheumatology care can save health systems more than $2,700 per patient per year.
- 公司
- - -
- 行业
- - -
跳出率
47.35%
每次访问页数
1.86
平均访问时长
00:00:49
跳出率
39.24%
每次访问页数
2.14
平均访问时长
00:00:21
rheumnow.com在 六月 2026 的前五名竞争对手是:lupus.bmj.com、sjogrenssyndromenews.com、ped-rheum.biomedcentral.com、rheuma.com.au等。
根据 Similarweb 的月访问量数据,rheumnow.com 在 六月 2026 的头号竞争对手是 lupus.bmj.com。与 rheumnow.com 相似度排名第二的网站是 sjogrenssyndromenews.com,排名第三的是 ped-rheum.biomedcentral.com。
在 六月 2026,rheuma.com.au 被评为与 rheumnow.com 相似度第四高的网站,skintherapyletter.com 位居第五。
进入前十名榜单的其他五家竞争对手分别是 my.rheumatology.org、ccrheumatology.com、northfloridahandandwrist.com、remissionmedical.com 和 radiographyonline.com。
